Preclinical model of protection against ionizing radiation | ||
Compound | Tissue/Organ Examined | Reference |
L-carnitine | Plasma, liver and erythrocytes | Dokmeci et al., 2006 [22] |
Cochlear damage | Altas et al., 2006 [23] | |
Oral mucositis and myelosuppression | Ucuncu et al., 2006 [24] | |
Eye cataracts | Kocer et al., 2007 [25] | |
Brain and retinal damages | Sezen et al., 2008 [26] | |
Testis-seminiferous tubules damage | Topcu-Tarladacalisir et al., 2009 [27] | |
Testicular damage | Kanter et al., 2010 [28] | |
Kidney damage | Caloglu et al., 2009, Cosar et al., 2011 [29] [30] | |
Ileal mucosal injury | Caloglu et al., 2012 [31] , Akpolat et al., 2013 [32] | |
Acetyl-L-carnitine | Lung and liver | Mansour, 2006 [33] |
Whole body effects and mortality | Babicová et al., 2013 [34] |